Accredo Split-Fill Drug List

January 2019 1199SEIU Benefit Funds Split-Fill Drug List

  • The specialty drugs on the Accredo Split-Fill list will be dispensed as a 14- or 15-day supply for six (6) consecutive fills during the initial three (3) months of drug therapy.
  • The specialty drugs are dispensed as a 14- or 15-day supply to allow drug dosage adjustments and/or changes in drug therapy, to promote clinical drug therapy management.
  • If a member remains on the specialty drug for longer than three (3) months, Accredo will fill a 30-day supply on the fourth (4th) month of drug therapy.
DrugsDisease State
ALECENSAOncology
BOSULIFOncology
CABOMETYXOncology
COPEGUSHepatitis C
DAKLINZAHepatitis C
EPCLUSAHepatitis C
ERIVEDGEOncology
EXJADEIron Toxicity
GLEEVEC (imatinib)Oncology
HARVONIHepatitis C
INLYTAOncology
IRESSAOncology
JADENUIron Toxicity
JAKAFIOncology
KALYDECOCystic Fibrosis
LENVIMAOncology
LYNPARZAOncology
MAVYRETHepatitis C
MODERIBAHepatitis C
NEXAVAROncology
NUPLAZIDParkinson’s Disease
OLYSIOHepatitis C
PEGASYSHepatitis C
REBETOLHepatitis C
RIBAPAKHepatitis C
RIBASPHEREHepatitis C
RIBATABHepatitis C
RIBAVIRINHepatitis C
SOVALDIHepatitis C
SPRYCELOncology
TAFLINAROncology
TARCEVAOncology
TARGRETIN (bexarotene)Oncology
TASIGNAOncology
VERZENIOOncology
VIEKIRA PAKHepatitis C
VOSEVIHepatitis C
VOTRIENTOncology
XALKORIOncology
XENAZINE (tetrabenazine)Huntington’s Chorea
XTANDIOncology
YONSAOncology
ZELBORAFOncology
ZEPATIERHepatitis C
ZOLINZAOncology
ZYKADIAOncology
ZYTIGAOncology
English
Español English